Compare BDAI & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDAI | HBIO |
|---|---|---|
| Founded | 1996 | 1901 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.7M | 26.5M |
| IPO Year | 2018 | 2000 |
| Metric | BDAI | HBIO |
|---|---|---|
| Price | $1.93 | $9.78 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.25 |
| AVG Volume (30 Days) | ★ 47.1K | 21.7K |
| Earning Date | 10-23-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,176,000.00 |
| Revenue This Year | N/A | $3.79 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.70 | $0.40 |
| 52 Week High | $2.77 | $9.60 |
| Indicator | BDAI | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 73.59 |
| Support Level | $1.84 | $5.91 |
| Resistance Level | $2.29 | N/A |
| Average True Range (ATR) | 0.34 | 0.48 |
| MACD | -0.03 | 0.09 |
| Stochastic Oscillator | 25.70 | 80.00 |
Biddance AI Systems Inc, formerly Hitek Global Inc, is a provider of information technology consulting and solutions services. The company has two lines of business services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from Hardware and equipment sales, Tax services, and Software sales.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.